Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Journal of Pharmaceutical Sciences
|
April 20, 2026
Reimagining Carrier-Based Formulations for Inhalation: Respirable Agglomerates
Jeffry G Weers, Thomas E Tarara, Danforth P Miller
AAPS Pharmscitech
|
February 9, 2019
Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles
Jeffry G Weers, Danforth P Miller, Thomas E Tarara
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
June 8, 2026
Design of Dry Powder Inhalers: 2. The Impact of Suboptimal Peak Inspiratory Flow Rates on Bronchodilation in Patients with Obstructive Lung Diseases
Jeffry G Weers, Thomas E Tarara, Danforth P Miller
Expert Opinion on Drug Delivery
|
May 11, 2007
Design of fine particles for pulmonary drug delivery
Jeffry G Weers, Thomas E Tarara, Andrew R Clark
Pharmaceutics
|
November 27, 2021
Targeting of Inhaled Therapeutics to the Small Airways: Nanoleucine Carrier Formulations
Danforth P Miller, Thomas E Tarara, Jeffry G Weers
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
June 8, 2026
Design of Dry Powder Inhalers: 1. Does Size Matter?
Jeffry G Weers, Thomas E Tarara, Danforth P Miller
Langmuir : the ACS Journal of Surfaces and Colloids
|
August 25, 2004
Characterization of fluorocarbon-in-water emulsions with added triglyceride
Jeffry G Weers, Rebecca A Arlauskas, Thomas E Tarara, et al.
Pharmaceutical Research
|
October 23, 2004
Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a
Thomas E Tarara, Michael S Hartman, Howard Gill, et al.
Molecular Pharmaceutics
|
June 9, 2015
Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs
Danforth P Miller, Trixie Tan, Thomas E Tarara, et al.
Molecular Pharmaceutics
|
April 19, 2017
Physical Characterization of Tobramycin Inhalation Powder: II. State Diagram of an Amorphous Engineered Particle Formulation
Danforth P Miller, Trixie Tan, John Nakamura, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Journal of Pharmaceutical Sciences
|
April 20, 2026
Reimagining Carrier-Based Formulations for Inhalation: Respirable Agglomerates
Jeffry G Weers, Thomas E Tarara, Danforth P Miller
AAPS Pharmscitech
|
February 9, 2019
Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles
Jeffry G Weers, Danforth P Miller, Thomas E Tarara
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
June 8, 2026
Design of Dry Powder Inhalers: 2. The Impact of Suboptimal Peak Inspiratory Flow Rates on Bronchodilation in Patients with Obstructive Lung Diseases
Jeffry G Weers, Thomas E Tarara, Danforth P Miller
Expert Opinion on Drug Delivery
|
May 11, 2007
Design of fine particles for pulmonary drug delivery
Jeffry G Weers, Thomas E Tarara, Andrew R Clark
Pharmaceutics
|
November 27, 2021
Targeting of Inhaled Therapeutics to the Small Airways: Nanoleucine Carrier Formulations
Danforth P Miller, Thomas E Tarara, Jeffry G Weers
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
June 8, 2026
Design of Dry Powder Inhalers: 1. Does Size Matter?
Jeffry G Weers, Thomas E Tarara, Danforth P Miller
Langmuir : the ACS Journal of Surfaces and Colloids
|
August 25, 2004
Characterization of fluorocarbon-in-water emulsions with added triglyceride
Jeffry G Weers, Rebecca A Arlauskas, Thomas E Tarara, et al.
Pharmaceutical Research
|
October 23, 2004
Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a
Thomas E Tarara, Michael S Hartman, Howard Gill, et al.
Molecular Pharmaceutics
|
June 9, 2015
Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs
Danforth P Miller, Trixie Tan, Thomas E Tarara, et al.
Molecular Pharmaceutics
|
April 19, 2017
Physical Characterization of Tobramycin Inhalation Powder: II. State Diagram of an Amorphous Engineered Particle Formulation
Danforth P Miller, Trixie Tan, John Nakamura, et al.
Page
of 2